Molecular genetics of familial nystagmus complicated with cataract and iris anomalies by Yan, Naihong et al.
Molecular genetics of familial nystagmus complicated with
cataract and iris anomalies
Naihong Yan,1 Yongwang Zhao,2 Yun Wang,1 Airui Xie,1 Haitao Huang,2 Wenhan Yu,1 Xuyang Liu,1
Su-ping Cai1
(The first three authors contributed equally to this work)
1Ophthalmic Laboratories & Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, P.R. China;
2Department of Ophthalmology, the Affiliated Hospital of Vocational Technology Institute of Yongzhou, Hunan Province, Yongzhou,
P.R. China
Purpose: Familial nystagmus complicated with cataract and iris anomalies are genetically heterogeneous, and the
pathophysiological mechanisms remain unclear. It is anticipated that mutations in the paired box 6 (PAX6) gene play a
major role in pathogenesis of malformations in anterior segment of the eye. In this study, we analyzed PAX6 in a Chinese
pedigree of nystagmus, cataract and iris anomalies. This study will provide insights into the genetic basis of this disease.
Methods: Complete ophthalmologic examinations were performed on four patients (excluding one dead patient) and four
unaffected individuals in this four-generation family. All coding exons of PAX6 were amplified by polymerase chain
reaction (PCR), sequenced and compared with reference database. The variations detected were evaluated in available
family members as well as 110 normal controls. Possible changes in structure and function of the protein induced by
amino acid variance were predicted by bioinformatics analysis.
Results: Nystagmus, cataract or iris anomalies were found in all patients of this family, but the severity was different
among these patients. A novel missense mutation in PAX6 was identified in all affected individuals but not in asymptomatic
members and 110 normal controls. This mutation causes an amino acid substitution of proline to glutamine at position
118 (p.P118Q) of the paired domain of the PAX6 protein. Such a change may cause structural and functional changes of
the protein based on bioinformatics analysis.
Conclusions: This study added a novel mutation to the existing spectrum of PAX6 mutations, suggesting that a mutation
in PAX6 correlated with anterior segment disorders observed in this family.
The anterior segment is the front third of the eye that
includes the structures in front of the vitreous humor: the
cornea, iris, ciliary body, and lens. Human anterior segment
anomalies are generally caused by disturbances early in the
development of the eye and have various hereditary patterns
[1,2]. Anterior segment anomalies are complex, continuous
spectrum of disorders, including iris anomalies, cataract and
nystagmus. Previous studies showed that a variety of anterior
segment  anomalies  may  be  associated  with  paired  box  6
(PAX6) gene mutations [3-5].
PAX6 (OMIM 607108, GenBank M93650), a member of
the paired box gene family, encodes a transcriptional regulator
involved in oculogenesis and other developmental processes
[6,7]. The human PAX6 gene located on chromosome 11p13,
with its role in oculogenesis first demonstrated as deleted or
mutated PAX6 was found in patients with iris anomalies [8,
9]. PAX6 spans 22 kb in size and consists of 14 exons and 13
introns  [10].  Mutations  in  PAX6  have  been  reported  in  a
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growing number of patients with iris anomalies and other
ocular malformations [11,12]. Currently there are around 700
mutations  identified  and  reported  in  the  PAX6  mutation
database [13].
In this study, mutation analysis of PAX6 was performed
in a large Chinese family with nystagmus, cataract, and iris
anomalies.
METHODS
Family recruitment: A four-generation Chinese family with
nystagmus, cataract, and iris anomalies was recruited from the
clinic  of  Department  of  Ophthalmology,  the  Affiliated
Hospital of Vocational Technology Institute of Yongzhou
(Figure 1). All individuals in the control group were healthy
and with no history of familial inherited ocular diseases. This
study  was  approved  by  West  China  Hospital,  Sichuan
University  Institute  Review  Board,  and  informed  consent
conforming to the tenets of the Declaration of Helsinki was
obtained from all participants.
Clinical examination: Complete physical examination and
detailed ophthalmological examination were conducted by an
experienced ophthalmologist on the affected and unaffected
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2612individuals,  including  Snellen  best-corrected  visual  acuity
test, slit-lamp microscopy examination, intraocular pressure
(IOP)  measurement,  Bultrasonic scan, and fundus
examination.
Mutation screening and sequence analysis: Genomic DNA
was extracted from 200 μl venous blood using a Qiamp Blood
Kit  (Qiagen,  Hilden,  Germany).  All  the  procedures  were
performed  according  to  manufacturer’s  protocol.  DNA
integrity was evaluated by 1% agarose gel electrophoresis.
The coding exons 4–13 of PAX6 with intronic flanking
sequences were amplified by PCR using previously published
primers [2,12] (Table 1). The primers were synthesized by
Invitrogen Company (Carlsbad, CA). PCRs were performed
in a MyCycler thermocycler (Bio-Rad, Hercules, CA) using
the following program: initial denaturation at 95 °C for 2 min
followed by 35 cycles of 94 °C for 10 s, 51 °C-56 °C for 30
s, and 72 °C for 1 min, and final extension at 72 °C for 5 min.
PCR  products  were  directly  sequenced  using  an  ABI
377XL  automated  DNA  sequencer  (Applied  Biosystems,
Foster City, CA). Sequence data were compared pair-wise
with  the  published  PAX6  sequence.  Mutation  was  named
according to the nomenclature recommended by the Human
Genomic Variation Society (HGVS).
Bioinformatics analysis: The Clustalw tool was used to align
the  protein  sequences  among  eight  different  species.  The
possible  functional  impact  of  an  amino  acid  change  was
Figure 1. Pedigree of the Chinese family
with  nystagmus,  cataract,  and  iris
anomalies. Filled squares and circles are
affected  males  and  females,
respectively.  Arrowhead  indicates
proband. The asterisk indicates family
members included this study.
TABLE 1. PRIMERS USED IN POLYMERASE CHAIN REACTION FOR AMPLIFICATION OF PAX6.
Exon Primer
direction
Sequence (5′→3′) Annealing temperature
(°C)
Product size
(bp)
4 Forward: AAGGGTAGATTTTGTATGCAC 54 276
  Reverse: GAAGTCCCAGAAAGACCAGA    
5 Forward: CCTCTTCACTCTGCTCTCTT 54 257
  Reverse: ATGAAGAGAGGGCGTTGAGA    
5a and 6 Forward: TGAAAGTATCATCATATTTGTAG 54 515
  Reverse: AGGAGAGAGCATTGGGCTTA    
7 Forward: CAGGAGACACTACCATTTGG 56 265
  Reverse: GACAGGCAAAGGGATGCAC    
8 Forward: GGGAATGTTTTGGTGAGGCT 54 346
  Reverse: TCTTTGTACTGAAGATGTGGC    
9 Forward: GTAGTTCTGGCACAATATGG 51 329
  Reverse: GCACTGTGTCTACGTCGAG    
10 and 11 Forward: CTCGACGTAGACACAGTGC 54 437
  Reverse: TTATGCAGGCCACCACCAGC    
12 Forward: GCTGTGTGATGTGTTCCTCA 54 245
  Reverse: AAGAGAGATCGCCTCTGTGC    
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2613predicted by Polyphen and SIFT. The isoelectric point (pI)
and molecular weight of the wild type and mutant protein were
analyzed by the Compute pI/Mw tool. The mutation region in
3D structure of PAX6 protein was analyzed by the Cn3D tool.
RESULTS
Clinical findings of the examined family: Four patients in four
successive generations of this family were found to have a
similar congenital ocular disorder. The segregation of the
ocular anomaly is consistent with an autosomal dominant
inheritance.
The proband (patient IV:2, a seven-year-old boy, Figure
1)  presented  with  nystagmus,  cataract,  and  iris  anomalies
(corectopia and coloboma of iris). In addition, this patient also
presented with mental retardation and muscle spasms. His
corrected visual acuity was 0.1 OD and 0.1 OS. Intraocular
pressure (IOP) was 17 mmHg in the right eye and 16.8 mmHg
in the left eye. He was noted to have nystagmus after birth.
Clinically,  he  showed  rapid  jerk  nystagmus  with  poorly
developed fixation ability (Figure 2A,B). B-scanning revealed
abnormally short axial lengths and deep anterior chambers
(data not shown). Fundus details could not be seen, but retinas
were attached per ultrasound.
The proband’s mother (Patient III:5, thirty-four-year-old,
Figure 1) was diagnosed with nystagmus, cataract, and mild
iris  defects  (irregular  pupils  and  mild  corectopia;  Figure
2C,D). Her visual acuity was 0.1 OD and 0.1 OS, and IOP was
10 mmHg OD and 13 mmHg OS. Fundus details could not be
seen.
The  proband’s  grandmother  (Patient  II:4,  fifty-three-
year-old, Figure 1) had mental illness. She became blind ten
years ago and had nystagmus, cataract and anomalies of iris
(data not shown). The proband’s great-grandmother (Patient
I:2, eighty-five-year-old, Figure 1) had various illness and was
bed-ridden  and  couldn’t  be  examined  by  slit-lamp
microscopy. She was blind for more than 30 years and had
nystagmus, cataract, and iris anomalies (She was examined
with direct ophthalmoscope and flashlight). Patient II:5 was
deceased in his thirties by accident. His elder sister recalled
that his vision was very poor and had nystagmus at his early
age.
Ocular abnormalities were not found in four unaffected
members examined in this family.
PAX6  mutation  identification  and  analysis:  A  novel
heterozygous mutation, c.353 C>A, at codon 118 (CCA to
CAA) of exon 6 in PAX6 was identified. This heterozygous
mutation was present in all affected individuals whereas none
of the unaffected family members and 110 normal control
Figure 3. Sequencing results of the PAX6 gene. A: a heterozygous C
to  A  transversion  at  codon  118  in  one  patient  from  the  family
(arrowhead). B: Wild type sequence from an unaffected member.
Figure 2. Anterior segment of proband
(IV:2) and the proband’s mother (III:5).
A  and  B  show  iris  anomalies,  and
nasally and superiorly displaced pupil
and cataract in both eyes of proband (IV:
2). C and D show mild nasally displaced
pupil  and  cataract  of  the  proband’s
mother (III:5).
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2614subjects  examined  carried  the  mutation  (Figure  3).  The
affected individuals were heterozygous alleles with mutant
and wild-type alleles. The unaffected members carried wild-
type alleles.
Bioinformatics  analysis:  PAX6  has  two  DNA-binding
domains, a paired domain (PD) and a homeodomain (HD) and
this mutation is in a paired domain. PAX6 with the c.353 C>A
mutation would result in replacement of proline by glutamine,
leading  to  a  change  of  a  hydrophobic  amino  acid  to  a
hydrophilic amino acid. Proline in this position was found
highly conserved for PAX6 by analyzing orthologs from eight
different species using Clustalw tool on line (Figure 4). The
p.P118Q mutation was predicted to be “probably damaging”
by  Polyphen  with  a  score  of  2.736,  and  “affect  protein
function” by SIFT with a score of 0.00. The theoretical pI of
mutant PAX6 was 9.45 and no change compared with wild
type  PAX6.  The  Mw  of  the  mutant  PAX6  was  slightly
increased  to  46714.39  Da  from  the  wild  type  PAX6  of
46683.37 Da. Cn3D tool analysis also showed that p.P118Q
mutation was located in the COOH-terminal region of PAX6
paired domain (Figure 5) [14].
DISCUSSION
All patients of this Chinese pedigree had different degree of
anterior segment anomalies since childhood. A 7-year-old
patient also presented with mental retardation and muscle
spasms.  The  disease  in  this  family  showed  autosomal
dominant  inheritance  and  the  main  symptoms  included
nystagmus,  cataract,  and  iris  anomalies.  The
pathophysiological  mechanisms  underlying  this  disease
remain unclear. Many studies showed that PAX6 is important
for  development  of  the  eye  and  central  nervous  tissues.
Dysfunction of PAX6 causes defects in eye development from
Drosophila to human, as PAX6 mutations are known to cause
eyeless in Drosophila, small-eye phenotype in the mouse, and
iris anomalies and Peters' anomaly in humans [3,15,16]. To
date, genetic analysis has detected numerous mutations of
PAX6 in patients with iris anomalies [13]. In this study, a
novel  heterozygous  mutation  (c.353  C>A,  p.P118Q)  in
PAX6 was identified in a Chinese pedigree. This mutation was
identified in all affected patients (I:2, II:4, III:5, and IV:2), but
not in unaffected family menbers and normal control subjects.
This  mutation  was  predicted  to  be  deleterious  by  both
Polyphen and SIFT with consistent results. Therefore, it was
considered  that  this  variation  appears  to  be  a  causative
mutation of the disease in this family.
PAX6 may regulate the expression of other genes during
embryogenesis  as  a  transcription  factor  [4,10].  PAX6
expresses two isoforms by alternative splicing, PAX6 (−5a;
422 amino acids) and PAX6 (+5a; 436 amino acids) [14,17].
The paired domain (PD) and homeodomain (HD) are two
DNA-binding  domains  of  PAX6  and  the  paired  domain
consists  of  128  amino  acids  and  contains  two  globular
subdomains (NH2-subdomain and COOH-subdomain) linked
by  an  extended  polypeptide  chain  [18,19].  This  novel
p.P118Q mutation was in the COOH-terminal region of the
paired domain. The p.P118Q mutation turned a hydrophobic
amino  acid  (proline)  into  a  hydrophilic  amino  acid
(glutamine), and since it is located in the hydrophobic core of
the COOH-subdomain, it may disrupt the folding and stability
of the whole protein (Figure 5). The proline at codon 118 is
highly  conserved  in  PAX6  paired-domains  of  all  species,
including  Mus  musculus,  Rattus  norvegicus,  Macaca
mulatta, Bos taurus, Gorilla gorilla, Gallus gallus, Danio
rerio, and Xenopus tropicalis (Figure 4). Such a high degree
of conservation argues for a functional importance of the
relevant amino acid residue.
A similar mutation, p.P118R (c.353 C>G), of PAX6 was
previously found in a Japanese family [5]. This family showed
a variety of congenital ocular disorders, including aniridia,
congenital nystagmus, minimal displaced pupil, and foveal
hypoplasia. The proline to glutamine (p.P118Q) substitution
in the COOH-terminal part of the paired domain reported here
has a phenotypic outcome different from that seen when the
same  residue  is  substituted  with  arginine  (p.P118R).  The
Human PAX6 Allelic Variant Database showed that at the
same codon more than 1 variant missense base-pair mutation
leading to production of different amino acids is found. This
illustrates  how  different  missense  mutations  affecting  the
same  codon  of  PAX6  may  result  in  distinctly  different
phenotypes [20].
Figure  4.  The  mutation  involved  a
highly conserved residue. The proline at
position  118  is  highly  conserved  for
PAX6,  which  was  demonstrated  by
analysis  of  orthologs  from  eight
different species.
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2615The affected individuals in this family showed congenital
ocular  disorders,  including  nystagmus,  cataract,  and  iris
anomalies. Besides these ocular symptoms, the proband (IV:
2) also had mental retardation and skeletal muscle spasms. His
grandmother  (II:4)  was  diagnosed  as  a  schizophrenic
disorder in her early 30s. PAX6 expresses in the developing
neural tissues of the brain, such as cerebellum, and plays a role
in the development of neural system and the eye [5,21]. Some
PAX6 mutations may play a critical role in controlling the
migration and differentiation of specific neuronal progenitor
cells in the brain [22]. Graziano et al. [23] reported a de novo
nonsense mutation S119R (serine to arginine) of PAX6 in a
patient  with  aniridia,  ataxia,  and  mental  retardation.  This
mutation may be responsible for aniridia, ptosis and cognitive
dysfunction.  Davis  et  al.  [24]  analyzed  of  a  patient  with
aniridia, autism, and mental retardation and identified a 1.3
Mb deletion of PAX6. Other findings also provided evidence
that the role of PAX 6 in brain anomalies associated with iris
anomalies [25,26].
In summary, this study added a novel missense mutation
to the existing spectrum of PAX6 mutations in a Chinese
family with nystagmus, cataract and iris anomalies. This study
provides  further  evidence  that  haploinsufficiency  of   the    
PAX6 gene  causes  defects  in  eye  development  and  it  also
adds more evidences for genetic  diagnosis of these inherited
disorders.
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